Jayasuriya Anula
SEC CIK 1822933 · EDGAR
BoughtSold
Most active insiders at JAGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chaturvedi Pravin R | CSO | — | — |
| 2 | Jayasuriya Anula | Dir | — | — |
| 3 | Wolin Jonathan S. | See Remarks | — | — |
| 4 | Lizak Carol R. | CFO | — | — |
| 5 | King Steven R. | See Remarks | — | — |
| 6 | Siegel Jonathan B. | Dir | — | — |
| 7 | BOCHNOWSKI JAMES J | Dir | — | — |
| 8 | MICEK JOHN | Dir | — | — |
| 9 | CONTE LISA A | See Remarks, Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-15 | 2025-12-11 | JAGX | Jaguar Health, Inc. | Jayasuriya Anula | Dir | A - Grant | $0.00 | +5,870 | 5,916 | +12,761% | $0 |
| 2024-01-02 | 2023-12-29 | LCTX | Lineage Cell Therapeutics, Inc. | Jayasuriya Anula | Dir | P - Purchase | $1.09 | +10.0K | 10.0K | New | +$10.9K | |
| DM | 2023-08-14 | 2023-07-01+ | JAGX | Jaguar Health, Inc. | Jayasuriya Anula | Dir | A - Grant | $0.00 | +70.3K | 1,718 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations